Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedNotice was added informing users of a lapse in government funding with a statement that the NIH Clinical Center is open and links for status updates (cc.nih.gov and opm.gov). The page's revision marker changed from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check9 days agoChange DetectedUI text updates: Show glossary appears as a selectable option, and the page now displays Last Update Submitted that Met QC Criteria and Last Update Posted. The No FEAR Act data label and the revision tag were updated from No FEAR Act data and Revision: v3.3.4 to No FEAR Act Data and Revision: v3.4.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedLocations sections were updated to add new sites across the US, Canada, Brazil, Australia, Spain, and other regions, while several previously listed locations were removed. This expands and refines where the trial is conducted.SummaryDifference2%

- Check73 days agoChange DetectedThe page now displays Revision: v3.3.2 instead of Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedRemoved the site-wide notice about a lapse in government funding displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.